TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
Oyama Y, Nagao S, Na L, Yanai K, Umebayashi M, Nakamura K, Nagai S, Fujimura A, Yamasaki A, Nakayama K, Morisaki T, Onishi H.
Oyama Y, et al. Among authors: yamasaki a.
Anticancer Res. 2021 Aug;41(8):4047-4052. doi: 10.21873/anticanres.15205.
Anticancer Res. 2021.
PMID: 34281873